PATENT CLAIM ANALYSIS

Application Number: 15948594
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "300000"]

Abstract:
Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines, [1,5]tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.

Claim (Index 19):
A method of treating a neoplastic disease in an animal in need thereof comprising administering a therapeutically effective amount of a compound or salt of  claim 1  to the animal.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 91.0
- Lexical Diversity: 1.5098
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11570707', '12974459', '14684871', '14021197', '11570703']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.9044856698103548
- 35 USC 102 Novelty (BERT): 0.6881649235038066
- Combined Prediction Score: 0.8828535951797
- Mean Citation Score: 765.912062
- Max Citation Score: 796.35455
- Similarity Product: 700.7569225108654

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test